Clinical information has low sensitivity for postmortem diagnosis of heart valve disease
- PMID: 28183793
- DOI: 10.1136/heartjnl-2016-310718
Clinical information has low sensitivity for postmortem diagnosis of heart valve disease
Abstract
Background: Accuracy of routinely collected information concerning cause of death is essential for public health and health systems planning. Since clinical examination has relatively low sensitivity for detection of valvular heart disease (VHD), mortality data based on clinical information alone might routinely underestimate the number of deaths due to VHD.
Methods: We compared autopsy findings against premortem clinical information for 8198 consecutive adult postmortems (mean age 69.1 years, 61.3% men), performed in a single UK tertiary referral centre with on-site cardiac surgical facilities over a 10-year period (2004-2013) during which 21% of the adult population underwent postmortem examination.
Results: Following postmortem, VHD was the principal cause of death in 165 individuals (2.0%), a principal or contributory cause ('any cause') of death in 326 (4.0%) and an incidental (ie, non-causal) finding in a further 346 (4.2%). Clinical documentation of VHD before death was highly specific but relatively insensitive for postmortem identification of VHD as the principal (specificity 96.8%; 95% CI 96.4% to 97.2%; sensitivity 69.7%, 95% CI 62.1% to 76.6%) or any (specificity 98.1%; 95% CI 97.8% to 98.4%; sensitivity 68.4%, 95% CI 63.1% to 73.4%) cause of death. VHD (principally aortic stenosis, endocarditis and rheumatic heart disease) was newly noted at postmortem and listed as a cause of death in 142 individuals (1.7%).
Conclusions: Clinical information recorded premortem is highly specific but relatively insensitive for the cause of death established at autopsy. Population-based mortality statistics that depend on premortem clinical information are likely to routinely underestimate the mortality burden of VHD.
Keywords: autopsy; death certificates; epidemiology; mortality; valvular heart disease.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Global epidemiology of valvular heart disease.Nat Rev Cardiol. 2021 Dec;18(12):853-864. doi: 10.1038/s41569-021-00570-z. Epub 2021 Jun 25. Nat Rev Cardiol. 2021. PMID: 34172950 Review.
-
Lack of progress in valvular heart disease in the pre-transcatheter aortic valve replacement era: increasing deaths and minimal change in mortality rate over the past three decades.Am Heart J. 2014 Apr;167(4):562-567.e2. doi: 10.1016/j.ahj.2013.12.030. Epub 2014 Jan 14. Am Heart J. 2014. PMID: 24655706
-
Survival of people with valvular heart disease in a large, English community-based cohort study.Heart. 2021 Aug;107(16):1336-1343. doi: 10.1136/heartjnl-2020-318823. Epub 2021 May 24. Heart. 2021. PMID: 34031157 Free PMC article.
-
Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank.Open Heart. 2022 Sep;9(2):e002039. doi: 10.1136/openhrt-2022-002039. Open Heart. 2022. PMID: 36104095 Free PMC article.
-
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).Europace. 2017 Nov 1;19(11):1757-1758. doi: 10.1093/europace/eux240. Europace. 2017. PMID: 29096024 Review.
Cited by
-
Global epidemiology of valvular heart disease.Nat Rev Cardiol. 2021 Dec;18(12):853-864. doi: 10.1038/s41569-021-00570-z. Epub 2021 Jun 25. Nat Rev Cardiol. 2021. PMID: 34172950 Review.
-
International normalized ratio for the guidance of warfarin treatment in elderly patients after cardiac valve replacement.Exp Ther Med. 2019 Feb;17(2):1486-1491. doi: 10.3892/etm.2018.7078. Epub 2018 Dec 10. Exp Ther Med. 2019. PMID: 30680032 Free PMC article.
-
Valvular Heart Disease Epidemiology.Med Sci (Basel). 2022 Jun 15;10(2):32. doi: 10.3390/medsci10020032. Med Sci (Basel). 2022. PMID: 35736352 Free PMC article. Review.
-
The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management.J Clin Med. 2023 Mar 10;12(6):2178. doi: 10.3390/jcm12062178. J Clin Med. 2023. PMID: 36983180 Free PMC article. Review.
-
Body Mass Index and Mortality from Nonrheumatic Aortic Valve Disease among Japanese Men and Women.J Atheroscler Thromb. 2023 Feb 1;30(2):150-159. doi: 10.5551/jat.63452. Epub 2022 Apr 13. J Atheroscler Thromb. 2023. PMID: 35418541 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical